- call +1-201-465-4211
- email sales@mrinsights.biz
PNH and aHUS, both are extremely rare and genetic diseases. Due to PNH, destruction of red blood cells of a person occurs quite sooner than it should. It is an acquired hematopoietic stem cell disorder. Hematopoietic stem cells are developed in bone marrow and eventually turn into red blood cells, white blood cells and platelets. A person with PNH has some defected hematopoietic cells which create defective red blood cells. These defective cells are highly susceptible to premature destruction by the complement system. aHUS is a disorders in which blood clots are formed in small blood vessels throughout the body. TMA can lead to heart stroke, attack, kidney failure and death. Soliris is the only drug treatment available in the market for treating these diseases.
Scope of the Report:
This report studies the PNH and aHUS market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the PNH and aHUS market by product type and applications/end industries.
The global PNH and aHUS market is expected to grow in future due to prolonged orphan drug market exclusivity, attractive orphan drug policies, increasing pharmaceutical R&D expenditure, rising health care expenditure. Key trends of this market include progressing drugs under pipeline, increasing prevalence of blood and bone marrow related disorders and favorable reimbursement policies. However, there are some factors which can hinder the market growth including high costs of drugs and associated risks.
The global PNH and aHUS market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of PNH and aHUS.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
Market Segment by Companies, this report covers
Alexion Pharmaceuticals
Alnylam Pharmaceuticals
Omeros Corporation
RA Pharmaceuticals
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
PNH
aHUS
Market Segment by Applications, can be divided into
Hospitals
Ambulatory Surgical Centers
Diagnostic Centers
Others
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 PNH and aHUS Market Overview
1.1 Product Overview and Scope of PNH and aHUS
1.2 Classification of PNH and aHUS by Types
1.2.1 Global PNH and aHUS Revenue Comparison by Types (2017-2023)
1.2.2 Global PNH and aHUS Revenue Market Share by Types in 2017
1.2.3 PNH
1.2.4 aHUS
1.3 Global PNH and aHUS Market by Application
1.3.1 Global PNH and aHUS Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Hospitals
1.3.3 Ambulatory Surgical Centers
1.3.4 Diagnostic Centers
1.3.5 Others
1.4 Global PNH and aHUS Market by Regions
1.4.1 Global PNH and aHUS Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) PNH and aHUS Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) PNH and aHUS Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) PNH and aHUS Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) PNH and aHUS Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) PNH and aHUS Status and Prospect (2013-2023)
1.5 Global Market Size of PNH and aHUS (2013-2023)
2 Manufacturers Profiles
2.1 Alexion Pharmaceuticals
2.1.1 Business Overview
2.1.2 PNH and aHUS Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Alexion Pharmaceuticals PNH and aHUS Revenue, Gross Margin and Market Share (2016-2017)
2.2 Alnylam Pharmaceuticals
2.2.1 Business Overview
2.2.2 PNH and aHUS Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Alnylam Pharmaceuticals PNH and aHUS Revenue, Gross Margin and Market Share (2016-2017)
2.3 Omeros Corporation
2.3.1 Business Overview
2.3.2 PNH and aHUS Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Omeros Corporation PNH and aHUS Revenue, Gross Margin and Market Share (2016-2017)
2.4 RA Pharmaceuticals
2.4.1 Business Overview
2.4.2 PNH and aHUS Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 RA Pharmaceuticals PNH and aHUS Revenue, Gross Margin and Market Share (2016-2017)
3 Global PNH and aHUS Market Competition, by Players
3.1 Global PNH and aHUS Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 PNH and aHUS Players Market Share
3.2.2 Top 10 PNH and aHUS Players Market Share
3.3 Market Competition Trend
4 Global PNH and aHUS Market Size by Regions
4.1 Global PNH and aHUS Revenue and Market Share by Regions
4.2 North America PNH and aHUS Revenue and Growth Rate (2013-2018)
4.3 Europe PNH and aHUS Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific PNH and aHUS Revenue and Growth Rate (2013-2018)
4.5 South America PNH and aHUS Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa PNH and aHUS Revenue and Growth Rate (2013-2018)
5 North America PNH and aHUS Revenue by Countries
5.1 North America PNH and aHUS Revenue by Countries (2013-2018)
5.2 USA PNH and aHUS Revenue and Growth Rate (2013-2018)
5.3 Canada PNH and aHUS Revenue and Growth Rate (2013-2018)
5.4 Mexico PNH and aHUS Revenue and Growth Rate (2013-2018)
6 Europe PNH and aHUS Revenue by Countries
6.1 Europe PNH and aHUS Revenue by Countries (2013-2018)
6.2 Germany PNH and aHUS Revenue and Growth Rate (2013-2018)
6.3 UK PNH and aHUS Revenue and Growth Rate (2013-2018)
6.4 France PNH and aHUS Revenue and Growth Rate (2013-2018)
6.5 Russia PNH and aHUS Revenue and Growth Rate (2013-2018)
6.6 Italy PNH and aHUS Revenue and Growth Rate (2013-2018)
7 Asia-Pacific PNH and aHUS Revenue by Countries
7.1 Asia-Pacific PNH and aHUS Revenue by Countries (2013-2018)
7.2 China PNH and aHUS Revenue and Growth Rate (2013-2018)
7.3 Japan PNH and aHUS Revenue and Growth Rate (2013-2018)
7.4 Korea PNH and aHUS Revenue and Growth Rate (2013-2018)
7.5 India PNH and aHUS Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia PNH and aHUS Revenue and Growth Rate (2013-2018)
8 South America PNH and aHUS Revenue by Countries
8.1 South America PNH and aHUS Revenue by Countries (2013-2018)
8.2 Brazil PNH and aHUS Revenue and Growth Rate (2013-2018)
8.3 Argentina PNH and aHUS Revenue and Growth Rate (2013-2018)
8.4 Colombia PNH and aHUS Revenue and Growth Rate (2013-2018)
9 Middle East and Africa Revenue PNH and aHUS by Countries
9.1 Middle East and Africa PNH and aHUS Revenue by Countries (2013-2018)
9.2 Saudi Arabia PNH and aHUS Revenue and Growth Rate (2013-2018)
9.3 UAE PNH and aHUS Revenue and Growth Rate (2013-2018)
9.4 Egypt PNH and aHUS Revenue and Growth Rate (2013-2018)
9.5 Nigeria PNH and aHUS Revenue and Growth Rate (2013-2018)
9.6 South Africa PNH and aHUS Revenue and Growth Rate (2013-2018)
10 Global PNH and aHUS Market Segment by Type
10.1 Global PNH and aHUS Revenue and Market Share by Type (2013-2018)
10.2 Global PNH and aHUS Market Forecast by Type (2018-2023)
10.3 PNH Revenue Growth Rate (2013-2023)
10.4 aHUS Revenue Growth Rate (2013-2023)
11 Global PNH and aHUS Market Segment by Application
11.1 Global PNH and aHUS Revenue Market Share by Application (2013-2018)
11.2 PNH and aHUS Market Forecast by Application (2018-2023)
11.3 Hospitals Revenue Growth (2013-2018)
11.4 Ambulatory Surgical Centers Revenue Growth (2013-2018)
11.5 Diagnostic Centers Revenue Growth (2013-2018)
11.6 Others Revenue Growth (2013-2018)
12 Global PNH and aHUS Market Size Forecast (2018-2023)
12.1 Global PNH and aHUS Market Size Forecast (2018-2023)
12.2 Global PNH and aHUS Market Forecast by Regions (2018-2023)
12.3 North America PNH and aHUS Revenue Market Forecast (2018-2023)
12.4 Europe PNH and aHUS Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific PNH and aHUS Revenue Market Forecast (2018-2023)
12.6 South America PNH and aHUS Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa PNH and aHUS Revenue Market Forecast (2018-2023)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
List of Tables and Figures
Figure PNH and aHUS Picture
Table Product Specifications of PNH and aHUS
Table Global PNH and aHUS and Revenue (Million USD) Market Split by Product Type
Figur
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
